Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • Compensation Framework Study
    • First Interim Report
    • Second Interim Report
    • The Inquiry Report
  • Publication Day
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • Confidential Psychological Support
    • Interim Payments
    • Support Groups
    • Get in touch
    • Infected Blood Support Schemes
    • Treatment and aftercare
    • Medical Evidence
    • Expenses Guidance
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

The first known death in the UK of a person with haemophilia with AIDS was recorded. The person died at the start of September 1983, having been unwell since he received commercial concentrate some months earlier.

  • Read more about The first known death in the UK of a person with haemophilia with AIDS was recorded. The person died at the start of September 1983, having been unwell since he received commercial concentrate some months earlier.

The Medical Research Council produced a brief on AIDS in which it said: "Over the last six months the possibility of transmission by blood transfusion has become increasingly apparent...An infectious agent has therefore been implicated which is sexually, parenterally and even perinatally transmitted with a long asymptomatic infectious incubation period...Transmission of AIDS by transfusion and blood products may become a serious problem."

  • Read more about The Medical Research Council produced a brief on AIDS in which it said: "Over the last six months the possibility of transmission by blood transfusion has become increasingly apparent...An infectious agent has therefore been implicated which is sexually, parenterally and even perinatally transmitted with a long asymptomatic infectious incubation period...Transmission of AIDS by transfusion and blood products may become a serious problem."

Dr Michael Rodell presented to a standing committee advising the US Secretary of State of Health and the Commissioner of the FDA and suggested that four infected persons could contaminate the entire world supply of Factor 8 concentrate.

  • Read more about Dr Michael Rodell presented to a standing committee advising the US Secretary of State of Health and the Commissioner of the FDA and suggested that four infected persons could contaminate the entire world supply of Factor 8 concentrate.

Dr Michael Rodell told a standing committee advising the US Secretary of State of Health and the Commissioner of the FDA that, on average, persons who were paid for their plasma had it collected between 40 and 60 times per year.

  • Read more about Dr Michael Rodell told a standing committee advising the US Secretary of State of Health and the Commissioner of the FDA that, on average, persons who were paid for their plasma had it collected between 40 and 60 times per year.

The Committee on Safety of Medicines Sub-Committee on Biological Products decided not to recommend that imports be suspended.

  • Read more about The Committee on Safety of Medicines Sub-Committee on Biological Products decided not to recommend that imports be suspended.

Transfusion International, a journal directed at transfusionists, observed in an editorial by an eminent physician that there was relatively strong evidence indicating that AIDS may be transmitted by blood.

  • Read more about Transfusion International, a journal directed at transfusionists, observed in an editorial by an eminent physician that there was relatively strong evidence indicating that AIDS may be transmitted by blood.

The Council of Europe followed the recommendations of the Committee of Experts on the risk of AIDS.

  • Read more about The Council of Europe followed the recommendations of the Committee of Experts on the risk of AIDS.

The directors of the Scottish National Blood Transfusion Service prepared a leaflet regarding the risk of AIDS, identifying people with haemophilia as being amongst the classes of those who could get AIDS.

  • Read more about The directors of the Scottish National Blood Transfusion Service prepared a leaflet regarding the risk of AIDS, identifying people with haemophilia as being amongst the classes of those who could get AIDS.

A report of the Committee of Experts on Blood Transfusion and Immunohaematology meeting concluded that although "Absolute proof that AIDS is caused by a transmissible infectious agent is not yet available", nonetheless, "the consensus in the Committee was that it should be regarded as such ".

  • Read more about A report of the Committee of Experts on Blood Transfusion and Immunohaematology meeting concluded that although "Absolute proof that AIDS is caused by a transmissible infectious agent is not yet available", nonetheless, "the consensus in the Committee was that it should be regarded as such ".

The FDA had licensed Hyland Laboratories to market dry-heated concentrate.

  • Read more about The FDA had licensed Hyland Laboratories to market dry-heated concentrate.

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 328
  • Page 329
  • Page 330
  • Page 331
  • Current page 332
  • Page 333
  • Page 334
  • Page 335
  • Page 336
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Inquiry

  • Home
  • About
  • Approach
  • Participate
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.